GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Sudarshan Pharma Industries Ltd (BOM:543828) » Definitions » YoY EBITDA Growth

Sudarshan Pharma Industries (BOM:543828) YoY EBITDA Growth : 55.25% (As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Sudarshan Pharma Industries YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Sudarshan Pharma Industries's YoY EBITDA Growth for the quarter that ended in Mar. 2025 was 55.25%.

Sudarshan Pharma Industries's EBITDA per Share for the six months ended in Mar. 2025 was ₹0.95.

Sudarshan Pharma Industries YoY EBITDA Growth Historical Data

The historical data trend for Sudarshan Pharma Industries's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sudarshan Pharma Industries YoY EBITDA Growth Chart

Sudarshan Pharma Industries Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only 56.02 50.00 160.85 -10.55 57.14

Sudarshan Pharma Industries Semi-Annual Data
Mar17 Mar18 Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 68.53 92.41 83.73 60.32 55.25

Sudarshan Pharma Industries YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Sudarshan Pharma Industries's YoY EBITDA Growth for the fiscal year that ended in Mar. 2025 is calculated as:

YoY EBITDA Growth (A: Mar. 2025 )
=(EBITDA per Share (A: Mar. 2025 )-EBITDA per Share (A: Mar. 2024 ))/ | EBITDA per Share (A: Mar. 2024 ) |
=(1.639-1.043)/ | 1.043 |
=57.14 %

Sudarshan Pharma Industries's YoY EBITDA Growth for the quarter that ended in Mar. 2025 is calculated as:

YoY EBITDA Growth (Q: Mar. 2025 )
=(EBITDA per Share (Q: Mar. 2025 )-EBITDA per Share (Q: Mar. 2024 )) / | EBITDA per Share (Q: Mar. 2024 )) |
=(0.947-0.61)/ | 0.61 |
=55.25 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sudarshan Pharma Industries YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Sudarshan Pharma Industries's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Sudarshan Pharma Industries Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Sudarshan Pharma Industries Ltd (BOM:543828) » Definitions » YoY EBITDA Growth
Comparable Companies
BOM:544272 BOM:506852 BOM:539195 BOM:506687 BOM:542012 BOM:506405 BOM:524342 BOM:506597 BOM:500298 BOM:500012 TSE:4063 SAU:2010 XTER:BAS DOW SHSE:600989 SHSE:600346 TSE:4091 XKRX:051910 SZSE:002493 SHSE:600160
Traded in Other Exchanges
N/A
Address
S V Road, 301, 3rd Floor, Aura Biplex, Above Kalyan Jewellers, Borivali (West), Mumbai, MH, IND, 400092
Website
https://www.sudarshanpharma.com
Sudarshan Pharma Industries Ltd is engaged in business in Pharmaceutical formulation & Chemical - Bulk drugs, API, Specialty chemicals, and Solvents in India and abroad.

Sudarshan Pharma Industries Headlines

No Headlines